Tracking baby health when moms with MS take ozanimod
NCT ID NCT05170126
Summary
This study aims to gather safety information for pregnant women with multiple sclerosis who take the medication ozanimod. Researchers will follow about 1,200 women in the US, Canada, and Germany to track health outcomes for both the mothers and their babies. The goal is to help future patients and doctors make better-informed decisions about using this medication during pregnancy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Evidera
RECRUITINGBethesda, Maryland, 20814, United States
Contact
-
Evidera INC.
RECRUITINGBethesda, Maryland, 20814, United States
Contact
-
Marienhospital Herne, Klinikum Der Ruhr-Universitaet Bochum
RECRUITINGHerne, 44625, Germany
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.